does semaglutide take time to work How Long It for Work? How Does Wegovy Work for

Description

Jean-Luc Faillie, MD, PhD, professor and head of the

Following the initial top-line readout in August which showed a statistically significant, 20% relative risk reduction in MACE-3 cardiovascular events the veil has finally been lifted from the landmark SELECT cardiovascular outcomes trial

Patients benefit from enhanced engagement and real-time monitoring, fostering adherence to treatment protocols and enabling a data-driven approach to long-term care.FDA Approval of Zepbound: A Turning PointThe FDAs approval of Zepbound marks a pivotal moment in sleep medicine

Key highlights: Once-daily oral administration Up to 11.8% weight loss over 36 weeks Focus on broader cardiometabolic health outcomes Advancement into Phase III development As obesity remains one of the most significant global health challenges, innovation in oral GLP-1 therapies could help improve accessibility and patient adherence while expanding treatment options beyond injectable therapies